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Abstract 
Aims: Drug interaction occurs when a drug affects the action of another. In this line, the present study has been 
conducted to determine the prevalence of potential drug interactions in critical care units.   
Methods: In the present retrospective study, the first twenty-four hour prescriptions of 371 patients admitted to 
intensive care unit of Shahid Bahonar hospital of Kerman were investigated in terms of the number and type of drug 
interaction in addition to other factors such as number of drugs, age, gender, length of ICU stay and number of 
prescribing doctors. In order to determine the number and type of drug interactions, a reference textbook of "Drug 
Interaction Facts" was used, and data analysis was performed by SPSS18 statistical software with respect to the study 
objectives using descriptive statistics, Pierson correlation test, independent t-test, and variance analysis.  
Results: In terms of the drugs received, 77 different drugs and, in total, 2091 cases of drug prescription were found with 
the average of 5.6 (±1.5) for each patient. Overall, 726 cases of drug interactions were observed among critical care unit 
patients in the first 24 hour of prescription. Delayed, moderate, and possible interactions were accounted for the most 
interactions found. The results are indicative of a significant correlation between the number of drug interactions and 
prescribed medications, age, gender, duration of hospitalizations and number of prescribing doctors. 
Conclusion: Due to possessing more risk factors of drug interactions, critical care unit patients are at higher risk of 
developing drug interaction which behooves the medical team to pay more attention to this issue. 
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Introduction 
Potential drug interaction is a situation in 
which a drug action is likely to be altered by 
the concurrent administration of another drugs 
[1] and can be observed in both 
pharmacokinetic and pharmacodynamic 
states. In pharmacokinetic intervention, a drug 
alters the absorption, distribution, 
metabolism, and the clearance of another 
drug, and in pharmacodynamic intervention, 
the drug specific performance is changed by 
the other drugs [2]. According to the Medical 
Association of America, 44 to 98 thousand 
deaths occur each year as a result of medical 
errors, seven thousands of which owing to 
negative side effects of drugs. Almost 6.7 
percent of patients admitted to hospital 
undergo adverse drug complications which 
bring about 0.34% mortality rate among this 
group. In 2000 in the United States of 
America, the fourth rank has been allocated to 
adverse drug effect-caused mortality after 
cardiovascular disease, diabetes and AIDS 
[3]. The risk and severity of drug interactions 
varies under the influence of factors such as 
number of medications received, duration of 
treatment, patients' age, the number of 
prescribing physicians and stage of disorder 
[1, 3].  
Critical care unit patients receive more 
medication compared to the patients in other 
wards [4] and are therefore more subjected to 
the risk of drug interactions [1, 2, 4, 5, 6]. In a 
study by Lima et al. in Brazil, 311 cases of 
potential drug interactions have been reported 
in critical care unit patients [5]. In this line, 
the results of a study by Hammes et al. in 
2008 [6] also indicated higher risk for the 
occurrence of potential drug interactions in 
intensive care unit patients. Limited studies 
have been conducted in this field in our 
country. In an investigation by Hajebi et al. 
performed in four wards of an educational 
hospital, 156 cases of drug interaction have 
been reported [7]. In another study by Nazari 
et al. (2004) in intensive care unit of one of 
the teaching hospitals in Tehran, 413 cases of 
potential drug interactions have been 
announced [4]. Although all drug interactions 
are not preventable, medical team's awareness 
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on the incidence of potential drug interactions 
and the risk factors increasing the possibility 
of drug interaction as well as familiarity with 
the mechanisms involved in this phenomenon 
can reduce the real occurrence of drug 
interactions among the patients hospitalized 
[5]. In this regard, the present study has been 
carried out to investigate the prevalence of 
potential drug interaction and the associated 
risk factors in critical care units of Shahid 
Bahonar hospital of Kerman.  
 
Methods 
The present retrospective study was 
undertaken to determine the prevalence of 
potential drug interactions and related risk 
factors in intensive care unit patients of 
Shahid Bahonar hospital of Kerman. To 
collect the information, medical records of all 
patients hospitalized in these wards from late 
March 2009 to late March 2010 were 
evaluated. The participants only included 
those who were directly transferred to 
intensive care units, for whom medical 
records had been established. The number of 
drugs received by patients in the first 24 hours 
of hospitalization in critical care units was 
extracted from patients' records. Other 
parameters such as the names of drugs 
received and their prescription patterns were 
also collected and recorded in the standard 
forms.  Patients' demographic information 
including age, gender, marital status, number 
of physicians, duration of hospitalization in 
the ward, and mode of discharge were 
accessed from Medical Record Department of 
hospital and recorded in information 
collecting forms. In order to determine drug 
interaction for each patient, the reference 
textbook of "Drug Interaction Facts", 
published in 2010, was applied [8]. In this 
book, drugs are arranged based on English 
alphabet, and type of interactions in terms of 
initiation (abrupt or delayed), intensity (low, 
medium and high) and possibility 
(established, probable, suspect, possible, and 
implausible) is separately specified for each 
drug. Those drugs for which the names were 
not mentioned in the book would be 
considered as non-interactive. Moreover, 
nutritional supplements, serums, electrolytes 
and vitamins have not been investigated. 
After determination of drug interactions and 
their mechanisms, data were analyzed by the 
researchers for all patients in accordance to 
the study objectives using SPSS18 statistical 
software by descriptive statistics, Pearson 




From a total of 371 patients studied, with the 
mean age of 39.8 (±22.1) years, 75.2% were 
male and the rest were female. The average 
number of prescribing physicians was 2.7 for 
each patient, and the average length of 
hospitalization in critical care unit was 17.7 
(17.4) days. In terms of patients discharge 
from these wards, 55.3%, 15.6% and 29.1% 
of participants were respectively discharged 
following recovery, the ward's follow up, and 
death among 371 patients admitted. In terms 
of type of drugs received, 77 different drugs 
and, in total, 2091 cases of drug prescription 
 
Table1. The list of the ten most consumed drugs in the Critical Care Unit 
Drug name Times of prescription Drug name Times of prescription 
1. Ranitidine 276 6.  Keflin 123 
2. Phenytoin 256 7.  Midazolam 97 
3. Ceftazidime 157 8.  Pantoprazole 84 
4. Morphine 150 9.  Dexamethasone 78 
5. Vancomycin 150 10.  Ceftriaxone 72 
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were found with the average of 5.6 (±1.5) for 
each patient. Injected drugs (shots) accounted 
for 1849 number of prescribed medications. 
With respect to the frequency of drug 
administration, ranitidine and phenytoin were 
the most consumed drugs with 276 and 256 
times prescription (Table 1). 
Overall, 726 cases of drug interactions were 
observed among critical care unit patients in 
the first 24 hours of prescription. In terms of 
initiation, intensity and possibility of drug 
interactions, delayed, moderate and probable 
types accounted for the largest percentage of 
drug interactions respectively. From the total 
of 726 cases of drug interaction found, 25 
were major interactions, eight of which was 
related to ranitidine-phenytoin interaction and 
seven cases to phenytoin-dopamine. The 
greatest number of drug interactions has also 
been observed between ranitidine and 
phenytoin with 213 cases. The results 
obtained by the Pearson correlation test are 
indicative of a significant difference between 
the number of drug interaction and the 
number of prescribed medications (p<0.001, 
r=0.563). The test also showed significant 
relationship between the number of drug 
interactions with the number of 
hospitalization days and prescribing 
physicians (p<0.05, r=0.32). The results of the 
mentioned test displayed an inverse 
relationship between the number of drug 
interactions and patients' age (p<0.05, 
r=0.127). To determine the correlation 
between the number of drug interactions and 
patients' gender, independent t-test was used 
and findings indicated more interactions in 
men compared to women (p<0.05). 
Furthermore, variance analysis represented a 
meaningful association between the number 
of drug interactions and patients' mode of 
discharge, so as drug interactions were higher 
in patients discharged from recovery (2.15 ± 
1.65) than deceased ones (1.73±1.32) and 




Previous studies have demonstrated high 
possibility of drug interaction in critical care 
unit patients [1, 2, 4, 5 and 6]. The results of 
the present study is also well indicative of 
high risk of drug interaction among patients in 
intensive care unit as 726 cases of interaction 
have been found in the first 24 hours of 
prescription in these wards. In a study by 
Almeida et al. (2010) on the prevalence of 
potential drug interactions in critical care 
units, interaction rate has been reported to be 
higher in these units compared to the others; 
on the explanation of this finding, Almeida et 
al. have stated that due to types of receiving 
drugs and special clinical status, intensive 
care unit patients are at high risk of drug 
interaction [1]. In an investigation by Lima et 
al. on 102 patients hospitalized in critical care 
unit, the risk of potential drug interaction has 
been reported to be high with 311 cases of 
interactions found [5]. In terms of initiation, 
intensity and possibility of drug interactions, 
delayed, moderate and probable types 
accounted for the largest percentage of drug 
interactions respectively. In this regard, 
Hammes et al. study revealed more than 59% 
cases of delayed type of drug interaction in 
critical care units as well as higher prevalence 
of moderate and possible types compared to 
the others [6]; on the explanation of this 
phenomenon, it can be stated that since a 
great percentage of interactions has been 
between the two most in demand drugs, 
ranitidine and phenytoin, between which the 
interaction was of delayed, moderate, and 
possible types in the present study, allocation 
of more interactions to delayed, moderate, 
and possible types seems to be rational. The 
most common interactions observed were 
associated to ranitidine and phenytoin, which 
were also the most consumed drugs in critical 
care units, as the stomach acid neutralizers 
and anticonvulsive drugs. Almeida study has 
similarly pointed to anticonvulsants and 
stomach acid neutralizers as the most 
consumed drugs after non-steroidal anti-
inflammatory drugs in intensive care units [1]. 
Approximately 75% to 100% of ICU patients 
are subject to developing peptic stress ulcers 
due to clinical problems they are facing, and 
preventive measures are hence performed for 
the most patients in risk [9]; stomach acid 
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neutralizing drugs, such as ranitidine, are 
currently the top priority to meet this goal 
[10]. In line with the results obtained by 
Nazari et al. in Tehran [4] and other 
investigations [1, 5], the study findings 
exhibited that the more the number of 
prescribed drugs for patients is, the more the 
possibility of drug interaction occurrence will 
be. More incidence of drug interaction 
proportional to the increase in the number of 
drugs received by patients appears to be 
reasonable. The results of the study also 
showed that men are at higher risk of drug 
interactions in critical care units compared to 
women, and the possibility of interactions 
have inverse relationship with patients' age. 
However, Lima et al. study displayed 
contradictory results, as they indicated higher 
risk of drug interactions in women and those 
over 60 years of age in intensive care units, 
which can be justified by higher percentage of 
women participated in their study compared 
to men and higher risk of drug interaction in 
this group as a result. They also declared that 
due to numerous and more serious clinical 
problems in patients over 60 years of age, the 
possibility of receiving more medications and 
the consequent occurrence of drug 
interactions is increased in this age group [5]. 
As noted, the results of the present study are 
inconsistent with those obtained by Lima et 
al.; however, a more in-depth look into the 
issue shows a relative association between the 
two studies. According to Lima et al., more 
prevalence of drug interactions in the elderly 
goes back to multiple and more severe 
problems in this age group; if the mentioned 
problems are the reasons behind higher 
incidence of drug interactions, more 
occurrence of interactions among young 
participants in the present study can be 
justified by high percentage of trauma 
patients, who are encountering more serious 
and numerous problems compared to other 
patients, admitted to critical care units in the 
present research on one hand, and high 
percentage of trauma patients in the young 
age group compared to the other age classes 
[11] on the other. More prevalence of drug 
interactions in women has also been ascribed 
by Lima et al. to more percentage of this 
gender participated in comparison with men; 
if it is reasonable to attribute more 
interactions in women to their more 
participation, the situation was reversed in the 
present study in which men outnumbered 
women in terms of participation, contributing 
to more possibility of interaction occurrence. 
However, similar to more occurrences of 
interactions in the young age group, more 
prevalence of potential drug interaction in 
males compared to females seems to be 
mostly owing to the difference in clinical 
status between the two genders; just as trauma 
occurrence is more prevalent in young people, 
severe traumas are 2.5 times higher in men 
than women [11, 12]; hence, men have been 
more likely to develop a worsening clinical 
status in the presents research in comparison 
with women, justifying more drug 
prescription and consequently more incidence 
of drug interactions.    
The study results also showed higher 
possibility of drug interactions in line with 
increase in the number of prescribing 
physicians. Likewise, greater number of 
prescribing doctors has been mentioned by 
Almeida et al. [1] as one of the reasons for the 
more occurrence of drug interaction. This 
finding can be explained by the fact that due 
to numerous clinical problems in critical care 
unit patients, they are examined by several 
clinical specialists, each of whom prescribes 
different drugs which, per se, contributes to 
increment in the number of medications 
received by patients and ultimately more drug 
interactions. The study results also displayed 
more hospitalization duration in critical care 
unit patients with more possibility of drug 
interaction, which is in consistence with the 
study by Hammes et al. in 2008 [6].   
Since the present investigation has only 
evaluated the incidence of potential drug 
interaction in the first 24 hours of 
hospitalization, it cannot be definitely 
concluded that whether drug interactions have 
led to more duration of ICU stay or not; 
nonetheless, it is likely that patients with 
more duration of ICU stay have been in more 
need of examination and treatment for their 
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dire clinical situation on one side, and have 
been examined by a large number of 
physicians on the other, resulting in an 
increase in the number of medications 
received and higher incidence of interactions. 
The relationship between the mode of patients 
discharge and the possibility of drug 
interaction has also been assessed for the first 
time in the present study, and the results are 
indicative of the more potential drug 
interactions in patients who have been 
discharged following recovery than deceased 
ones and the other patients. Considering 
patients' serious condition which leads to 
more medications administration and 
consequently higher potential drug 
interactions, and given the more deleterious 
status of deceased patients compared to the 
others, a question is raised in this regard that 
why the number of drug interactions is less in 
deceased patients than those who have been 
discharged after recovery or the ward's follow 
up. A compelling reason to answer the 
question is that in spite of critical situations of 
deceased patients, they were most likely to 
die in the first hours of hospitalization in the 
ICU and had therefore spent less time in the 
ward instead of 24 hours (three working 
shifts) and received less medication, probably 
once in each shift instead of three times, 
which eventuated in less medication 
administration in these patients compared to 
recovered ones and, thus, lower possibility of 
drug interactions occurrence in this group. In 
terms of drug administration in critical care 
units, injection, with 1841 cases, was 
determined to be the most common method 
used in these wards.  
Lima et al. have similarly pointed to 
intravenous injection as the most frequent 
way of drug administration in their study, 
which could be owing to more serious clinical 
condition of these patients, raising the need to 
more prompt administration of drugs, and 
intravenous injection as the best possible 
option for this purpose [5]. Of course, some 
patients' inability to receive oral medications, 
receiving a greater volume of drugs through 
intravenous administration, and allowing 
drugs to be infused can also be enumerated as 
the reasons for intravenous injection as the 




Taken together, it can be concluded that the 
prevalence of potential drug interaction is 
high in critical care units and is influenced by 
factors such as a large number of drugs 
received by patients, serious and numerous 
clinical problems, a great number of 
prescribing physicians, and intravenous route 
for drug injection. Although all the potential 
drug interactions do not show up as the actual 
ones, high prevalence of potential drug 
interactions can be a warning bell for the 
incidence of actual drug interactions in 
critical care unit patients [1]; therefore, it 
requires medical team to pay further attention 
to this issue for preventive measures.  
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